BACKGROUND: Wiskott-Aldrich syndrome protein-deficient patients and mice are immunodeficient and can develop inflammatory bowel disease. The intestinal microbiome is critical to the development of colitis in most animal models, in which Helicobacter spp. have been implicated in disease pathogenesis. We sought to determine the role of Helicobacter spp. in colitis development in Wiskott-Aldrich syndrome protein-deficient (WKO) mice. METHODS: Feces from WKO mice raised under specific pathogen-free conditions were evaluated for the presence of Helicobacter spp., after which a subset of mice were rederived in Helicobacter spp.-free conditions. Helicobacter spp.-free WKO animals were subsequently infected with Helicobacter bilis. RESULTS: Helicobacter spp. were detected in feces from WKO mice. After rederivation in Helicobacter spp.-free conditions, WKO mice did not develop spontaneous colitis but were susceptible to radiation-induced colitis. Moreover, a T-cell transfer model of colitis dependent on Wiskott-Aldrich syndrome protein-deficient innate immune cells also required Helicobacter spp. colonization. Helicobacter bilis infection of rederived WKO mice led to typhlitis and colitis. Most notably, several H. bilis-infected animals developed dysplasia with 10% demonstrating colon carcinoma, which was not observed in uninfected controls. CONCLUSIONS: Spontaneous and T-cell transfer, but not radiation-induced, colitis in WKO mice is dependent on the presence of Helicobacter spp. Furthermore, H. bilis infection is sufficient to induce typhlocolitis and colon cancer in Helicobacter spp.-free WKO mice. This animal model of a human immunodeficiency with chronic colitis and increased risk of colon cancer parallels what is seen in human colitis and implicates specific microbial constituents in promoting immune dysregulation in the intestinal mucosa.
BACKGROUND:Wiskott-Aldrich syndrome protein-deficientpatients and mice are immunodeficient and can develop inflammatory bowel disease. The intestinal microbiome is critical to the development of colitis in most animal models, in which Helicobacter spp. have been implicated in disease pathogenesis. We sought to determine the role of Helicobacter spp. in colitis development in Wiskott-Aldrich syndrome protein-deficient (WKO) mice. METHODS: Feces from WKO mice raised under specific pathogen-free conditions were evaluated for the presence of Helicobacter spp., after which a subset of mice were rederived in Helicobacter spp.-free conditions. Helicobacter spp.-free WKO animals were subsequently infected with Helicobacter bilis. RESULTS: Helicobacter spp. were detected in feces from WKO mice. After rederivation in Helicobacter spp.-free conditions, WKO mice did not develop spontaneous colitis but were susceptible to radiation-induced colitis. Moreover, a T-cell transfer model of colitis dependent on Wiskott-Aldrich syndrome protein-deficient innate immune cells also required Helicobacter spp. colonization. Helicobacter bilisinfection of rederived WKO mice led to typhlitis and colitis. Most notably, several H. bilis-infected animals developed dysplasia with 10% demonstrating colon carcinoma, which was not observed in uninfected controls. CONCLUSIONS: Spontaneous and T-cell transfer, but not radiation-induced, colitis in WKO mice is dependent on the presence of Helicobacter spp. Furthermore, H. bilisinfection is sufficient to induce typhlocolitis and colon cancer in Helicobacter spp.-free WKO mice. This animal model of a humanimmunodeficiency with chronic colitis and increased risk of colon cancer parallels what is seen in humancolitis and implicates specific microbial constituents in promoting immune dysregulation in the intestinal mucosa.
Authors: Christoph Klein; Deanna Nguyen; Ching-Hui Liu; Atsushi Mizoguchi; Atul K Bhan; Hiroaki Miki; Tadaomi Takenawa; Fred S Rosen; Fred W Alt; Richard C Mulligan; Scott B Snapper Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: J R Archer; S Romero; A E Ritchie; M E Hamacher; B M Steiner; J H Bryner; R F Schell Journal: J Clin Microbiol Date: 1988-01 Impact factor: 5.948
Authors: Deanna D Nguyen; Marc-Andre Wurbel; Jeremy A Goettel; Michelle A Eston; Osub S Ahmed; Romela Marin; Elisa K Boden; Eduardo J Villablanca; Helena Paidassi; Vineet Ahuja; Hans-Christian Reinecker; Edda Fiebiger; Adam Lacy-Hulbert; Bruce H Horwitz; J Rodrigo Mora; Scott B Snapper Journal: Gastroenterology Date: 2012-06-15 Impact factor: 22.682
Authors: Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine Escobar; Phil Morrissey; Joanne L Viney Journal: Am J Pathol Date: 2002-02 Impact factor: 4.307
Authors: Sophie Dupuis-Girod; Jacques Medioni; Elie Haddad; Pierre Quartier; Marina Cavazzana-Calvo; Françoise Le Deist; Geneviève de Saint Basile; Jean Delaunay; Klaus Schwarz; Jean-Laurent Casanova; Stephane Blanche; Alain Fischer Journal: Pediatrics Date: 2003-05 Impact factor: 7.124
Authors: J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward Journal: J Clin Microbiol Date: 1994-05 Impact factor: 5.948
Authors: Susan E Erdman; Theofilos Poutahidis; Michal Tomczak; Arlin B Rogers; Kathleen Cormier; Benjamin Plank; Bruce H Horwitz; James G Fox Journal: Am J Pathol Date: 2003-02 Impact factor: 4.307
Authors: Z Shen; A Mannion; M T Whary; S Muthupalani; A Sheh; Y Feng; G Gong; P Vandamme; H R Holcombe; B J Paster; J G Fox Journal: Infect Immun Date: 2016-07-21 Impact factor: 3.441
Authors: Mark T Whary; Chuanwu Wang; Catherine F Ruff; Mallory J DiVincenzo; Caralyn Labriola; Lillian Ge; Yan Feng; Zhongming Ge; Vasu Bakthavatchalu; Suresh Muthupalani; Bruce H Horwitz; James G Fox Journal: Comp Med Date: 2020-04-29 Impact factor: 0.982
Authors: Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox Journal: Carcinogenesis Date: 2016-09-21 Impact factor: 4.944
Authors: Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; Frauke Drees; Zhongming Ge; Yan Feng; Xiaowei Chen; Guanyu Gong; Karan K Nagar; Timothy C Wang; Frank B Gertler; James G Fox Journal: PLoS One Date: 2016-04-05 Impact factor: 3.240
Authors: Maria Carmina Castiello; Francesca Pala; Lucia Sereni; Elena Draghici; Donato Inverso; Aisha V Sauer; Francesca Schena; Elena Fontana; Enrico Radaelli; Paolo Uva; Karla E Cervantes-Luevano; Federica Benvenuti; Pietro L Poliani; Matteo Iannacone; Elisabetta Traggiai; Anna Villa; Marita Bosticardo Journal: Front Immunol Date: 2017-05-02 Impact factor: 7.561